Σύγκριση μεθόδων

	Διαγενωμικές Μελέτες Συσχέτισης Βάσει Δικτύου	Μελέτη Συσχέτισης σε Επίπεδο Γονιδιώματος (GWAS)
Πεδίο	Βιοπληροφορική	Βιοπληροφορική
Οικογένεια	Process / pipeline	Process / pipeline
Έτος προέλευσης	2011–2013 (early tools); mature framework by 2015	2005–2007
Δημιουργός	Jia et al. (dmGWAS, 2011); Baranzini et al.; multiple concurrent groups	Klein et al. (age-related macular degeneration GWAS, 2005); landmark scale: Wellcome Trust Case Control Consortium (2007)
Τύπος	Network-augmented association analysis	Observational genomic association study
Θεμελιώδης πηγή	Wang, Q., Yu, H., Zhao, Z., & Jia, P. (2015). EW_dmGWAS: edge-weighted dense module search for genome-wide association studies and gene expression profiles. Bioinformatics, 31(15), 2591–2594.	Wellcome Trust Case Control Consortium. (2007). Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature, 447(7145), 661–678.
Εναλλακτικές ονομασίες	network GWAS, gene network GWAS, network-informed GWAS, NbGWAS	GWAS, genome-wide association analysis, whole-genome association study, WGAS
Συναφείς	6	6
Σύνοψη	Network-based GWAS integrates conventional genome-wide association study results with biological network data — such as protein-protein interaction (PPI) networks or gene co-expression graphs — to identify disease-relevant gene modules or subnetworks. Instead of reporting only the top individual SNPs, this approach propagates association signals through molecular interaction networks, surfacing gene clusters whose collective signal implicates them in complex-trait biology even when no single variant reaches genome-wide significance alone.	A genome-wide association study (GWAS) systematically tests hundreds of thousands to millions of single-nucleotide polymorphisms (SNPs) across the human genome for statistical association with a trait or disease. By comparing allele frequencies between cases and controls — or by regressing SNP genotypes on a quantitative phenotype — GWAS identifies genomic loci that harbor common genetic variants contributing to complex traits. Since its large-scale debut in 2007, GWAS has catalogued thousands of robust disease–variant associations across virtually every common human condition.